Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V9MV
|
||||
| Former ID |
DIB016503
|
||||
| Drug Name |
IDDBCP226234
|
||||
| Synonyms |
Serine/threonine-protein kinase PIM-2 inhibitor (inflammation), Boehringer Ingelheim
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543564] | ||
| Company |
Boehringer Ingelheim Corp
|
||||
| Canonical SMILES |
c1c(nc(cn1)c1cccc(c1)/C=C/C(=O)O)N[C@@H]1CC[C@H](CC1)N
|
||||
| Target and Pathway | |||||
| Target(s) | Serine/threonine-proteinkinase pim-2 | Target Info | Inhibitor | [543564] | |
| KEGG Pathway | Acute myeloid leukemia | ||||
| WikiPathways | Hematopoietic Stem Cell Differentiation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.